Glow 50/10/10 — Triple Peptide Blend
Three extensively studied peptides, each with a different mechanism, combined in a single vial. GHK-Cu brings copper-dependent gene expression modulation and ECM remodeling (150+ published studies). BPC-157 brings nitric oxide pathway interactions and connective tissue research (100+ studies). TB-500 brings actin regulation, cell migration, and cardiac tissue research. Together they cover three distinct but related signaling axes in one reconstitution. Buy Glow 50/10/10
What is in the vial
GHK-Cu (50mg)
Naturally occurring copper tripeptide (Gly-His-Lys:Cu²⁺). Influences expression of ~4,048 genes per Broad Institute cMap data. Upregulates collagen, growth factors, and GAGs while downregulating inflammatory mediators. CAS 89030-95-5.
BPC-157 (10mg)
15-amino acid gastric pentadecapeptide. Stable enough to be detected in biological samples up to 4 days post-administration. Research spans gastrointestinal mucosal integrity, connective tissue models, and VEGFR2-Akt-eNOS signaling. CAS 137525-51-0. Buy Glow 50/10/10
TB-500 (10mg)
43-amino acid thymosin beta-4 analog. The LKKTETQ motif at positions 17-23 is the actin-binding active region. Published in Nature for cardiac cell survival via ILK/Akt signaling. CAS 77591-33-4. Glow 50/10/10
Specifications
| Total Content | 70mg per vial (50/10/10) |
| Format | Co-lyophilized powder |
| Testing | Third-party tested, each component verified |
For laboratory research use only. Not for human or veterinary use.




Reviews
There are no reviews yet.